Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jonas Müntze

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After One Year

Clinical Pharmacology and Therapeutics

English

Α-Galactosidase a Genotype N215S Induces a Specific Cardiac Variant of Fabry DiseaseCLINICAL PERSPECTIVE

Circulation: Cardiovascular Genetics

English

Related publications

Pregnancy Outcome After Exposure to Migalastat for Fabry Disease: A Clinical Report

Case Reports in Obstetrics and Gynecology

English

Strong Increase of Leukocyte Apha‐galactosidase a Activity in Two Male Patients With Fabry Disease Following Oral Chaperone Therapy

Molecular genetics & genomic medicine

Molecular Biology

English

Safety of Switching to Migalastat From Enzyme Replacement Therapy in Fabry Disease: Experience From the Phase 3 ATTRACT Study

American Journal of Medical Genetics, Part A

English

Quantitative Changes of Melanoma-Associated Antigens as a Biomarker for Targeted Therapy Response

Experimental Dermatology

Molecular Biology

English

After One Year

International Journal of Plant Biology

English

After One Year ...

English

Serum Osteoprotegerin as a Biomarker for Vascular Disease

American Journal of Cardiology

Cardiovascular Medicine

English

Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation

American Journal of Transplantation

Transplantation

English

Renal Aspects and Enzyme Replacement Therapy of Fabry Disease

English